Skip to main content
logo
ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
17.68
+0.35 (1.99%)
At close: Oct 8, 2026, 4:00 PM EDT
17.41
-0.27 (-1.50%)
After-hours: Oct 8, 2026, 7:30 PM EDT

ADARx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Market Capitalization
1,981--
Market Cap Growth
---
Enterprise Value
1,560--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Debt / Equity Ratio
0.070.050.02
Debt / FCF Ratio
-0.03-
Net Debt / Equity Ratio
-3.94-3.04-0.98
Net Debt / EBITDA Ratio
4.005.413.74
Net Debt / FCF Ratio
4.66-1.824.39
Asset Turnover
-0.01-
Quick Ratio
12.5615.7524.56
Current Ratio
12.9816.1825.25
Return on Equity (ROE)
--38.89%-
Return on Assets (ROA)
--14.90%-
Return on Capital Employed (ROCE)
-25.20%-18.50%-25.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Buyback Yield / Dilution
--3.34%-
SEC Filings: 10-K · 10-Q